Leap Therapeutics reported mixed results on Tuesday for an experimental treatment in gastric and colorectal cancer, ...

KFF analysis highlights that ACA marketplace insurers denied 19% of claims. Less than 1% of denials were appealed, and ...

Robert F. Kennedy Jr. will sit before a Senate committee on Wednesday and provide the first substantive glimpse into how he ...

Another obesity biotech emerged on Tuesday morning, this time taking a different approach to the GIP antagonism story than ...

ITM-11 beats everolimus in Phase 3 GEP-NETs trial; ITM plans filing. Drug will compete with Novartis's Lutathera. Both use ...

Affini-T Therapeutics appears to have cut staff last week, according to LinkedIn posts from people who say they are or were ...

Sarepta Therapeutics unveiled new results from the second part of a clinical trial for its Duchenne muscular dystrophy gene ...

The state of Hawaii can proceed with a lawsuit against the three largest pharmacy benefit managers after it updated its ...

In its latest move to expand its portfolio, Lantheus Holdings is spending $250 million upfront to buy radiopharma CDMO and ...

Pfizer will pay nearly $60 million to settle claims that its subsidiary Biohaven used illegal kickbacks to drive sales of its ...

Found, a telehealth startup that treats obesity with medication and lifestyle coaching, unveiled new research showing tens of ...

For MASH developers, a race for cash: Akero Therapeutics aims to raise $300 million in an offering ...